The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice

Lignende værker

• Lack of endogenous cholecystokinin promotes cholelithogenesis in mice
  af: Wang, Helen H., et al.
  Udgivet: (2015)
• Update on the Molecular Mechanisms Underlying the Effect of Cholecystokinin and Cholecystokinin-1 Receptor on the Formation of Cholesterol Gallstones
  af: Wang, Helen H., et al.
  Udgivet: (2019)
• Activation of Estrogen Receptor G Protein–Coupled Receptor 30 Enhances Cholesterol Cholelithogenesis in Female Mice
  af: Wang, Helen H., et al.
  Udgivet: (2020)
• Transgenic Overexpression of Abcb11 Enhances Biliary Bile Salt Outputs, But Does Not Affect Cholesterol Cholelithogenesis in Mice
  af: Wang, Helen H., et al.
  Udgivet: (2010)
• Impaired intestinal cholecystokinin secretion, a fascinating but overlooked link between celiac disease and cholesterol gallstone disease
  af: Wang, Helen H., et al.
  Udgivet: (2017)